17b-estradiol

1 clinical trials involving this therapy/drug

This is not medical advice - consult your oncologist

Descriptions are automatically translated with AI assistance. Always verify details in the original on ClinicalTrials.gov and consult your treating physician.

RecruitingPhase IFemale onlyBreast cancer Hormone receptor positive (HR+)Metastatic / advanced

Estradiol Plus Olaparib for Breast Cancer (PHOEBE)

NCT05900895ClinicalTrials.gov ↗

Determine the safety and recommended Phase II dose of olaparib in combination with 17b-estradiol in post-menopausal patients with advanced ER+/HER2- breast cancer.

Full details →

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.